Stanislaw Burzynski's fight to bring his antineoplaston cancer therapy through FDA-sanctioned clinical trials continues in this sequel, which follows patients at the Burzynski Clinic in Houston as they undergo treatment while the trials remain open but stalled. Interviews with families track the daily reality of receiving an experimental therapy that insurers won't cover and regulators won't fully approve, alongside physicians and researchers who back Burzynski's claims about antineoplastons targeting cancer cells. The film spends much of its runtime on what it presents as a pattern of institutional resistance, from FDA scrutiny to what former patients and staff describe as harassment and intimidation aimed at the clinic. Archival footage of hearings and internal documents is used to build the case that Burzynski has been fighting a bureaucratic war for decades even as some patients credit him with remission. It is advocacy filmmaking, openly on Burzynski's side, but it is built from real interviews, clinical footage, and documentary evidence rather than stock imagery.